These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22237440)

  • 1. Caregiver opinions about fragile X population screening.
    Bailey DB; Bishop E; Raspa M; Skinner D
    Genet Med; 2012 Jan; 14(1):115-21. PubMed ID: 22237440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
    Archibald AD; Jaques AM; Wake S; Collins VR; Cohen J; Metcalfe SA
    Am J Med Genet A; 2009 Dec; 149A(12):2731-8. PubMed ID: 19938084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.
    Archibald AD; Hickerton CL; Jaques AM; Wake S; Cohen J; Metcalfe SA
    Am J Med Genet A; 2013 Jan; 161A(1):48-58. PubMed ID: 23239566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward prenatal screening and testing for Fragile X.
    Fanos JH; Spangner KA; Musci TJ
    Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening.
    Metcalfe SA; Martyn M; Ames A; Anderson V; Archibald AD; Couns GDG; Carter R; Cohen J; Cotter M; GenCouns M; Dang W; Delatycki MB; Donath S; Edwards S; Educ PD; Couns GDG; Forbes R; Couns GDG; Gavrila M; MedSci M; Halliday J; Hickerton C; Hill M; Couns GDG; Jacobs L; Ultrasound PD; Petrou V; Couns GDG; Plunkett L; GenCouns M; Sheffield L; Racp F; Thornton A; Couns GDG; Younie S; Econ PDH; Emery JD
    Genet Med; 2017 Dec; 19(12):1346-1355. PubMed ID: 28661491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X screening: attitudes of genetic health professionals.
    Acharya K; Ross LF
    Am J Med Genet A; 2009 Feb; 149A(4):626-32. PubMed ID: 19291766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal attitudes to newborn screening for fragile X syndrome.
    Christie L; Wotton T; Bennetts B; Wiley V; Wilcken B; Rogers C; Boyle J; Turner C; Hansen J; Hunter M; Goel H; Field M
    Am J Med Genet A; 2013 Feb; 161A(2):301-11. PubMed ID: 23303663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening.
    Bailey DB; Wheeler A; Berry-Kravis E; Hagerman R; Tassone F; Powell CM; Roche M; Gane LW; Sideris J
    Pediatrics; 2015 Aug; 136(2):e433-40. PubMed ID: 26169437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines.
    Johansen Taber K; Lim-Harashima J; Naemi H; Goldberg J
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1024. PubMed ID: 31694075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.
    Ames AG; Jaques A; Ukoumunne OC; Archibald AD; Duncan RE; Emery J; Metcalfe SA
    Health Expect; 2015 Feb; 18(1):69-80. PubMed ID: 23067225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.
    Boardman FK
    J Genet Couns; 2021 Feb; 30(1):85-97. PubMed ID: 33184995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Fragile X Syndrome: parent attitudes and perspectives.
    Skinner D; Sparkman KL; Bailey DB
    Genet Med; 2003; 5(5):378-84. PubMed ID: 14501833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
    Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
    J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of prenatal carrier screening for fragile X syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Fenwick RG; Sun W
    Genet Med; 2007 Jan; 9(1):46-51. PubMed ID: 17224689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.